Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Detact Diagnostics logo — We develop solutions to expensive and life-threatening infec...

Detact Diagnostics

We develop solutions to expensive and life-threatening infections in both the medical and food industries.

Founded 2014 The Netherlands The Netherlands 10 employees Venture round Total: $2.10M Biotechnology, Health Care +1

General Information

Company Name Detact Diagnostics
Founded Year 2014
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Detact Diagnostics. To contact Detact Diagnostics, visit detactdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Detact Diagnostics compare?

A PDF of Detact Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Detact Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Detact Diagnostics

Detact Diagnostics, a biotechnology and healthcare startup founded in 2014, is based in The Netherlands. The company's slogan "We develop solutions to expensive and life-threatening infections in both the medical and food industries" underscores its commitment to innovation in bacterial detection. Detact Diagnostics aims to address the vital need for bacterial detection to sustain healthy living. The company's mission is to prevent bacterial contamination by producing reliable, affordable, easy, and fast bacterial detection solutions. This focus on practical and accessible solutions sets Detact Diagnostics apart in the industry. The latest milestone for the company is the Venture Round investment at 17 December 2020, which saw investments from Pacific6 Enterprises, JM Molina Investments. Detact Diagnostics' innovative approach to addressing bacterial infections positions it as a promising investment opportunity. As a venture capital investor, the company's commitment to affordable, effective solutions in the critical fields of healthcare and food industry safety presents a compelling opportunity for potential growth and impact.

Business keywords: bacterial detection, infection prevention, medical industry, b-Swab, real-time detection, patented technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Pacific6 Enterprises
Pacific6 Enterprises, JM Molina Investments
17 Dec 2020
Venture Round €2.10M 1
NV NOM
NV NOM
19 Apr 2017

Detact Diagnostics Alternatives & Competitors

View All Alternatives
Detact Diagnostics vs
Nebula Biocides GmbH
Nebula Biocides GmbH Germany

Stop Spread - Save Lives

Seed
5 employees
Biotechnology, Health Care
Detact Diagnostics vs
TOM Thermochromic
TOM Thermochromic Bulgaria

The Appliaction with Thermochromic Effect allows monitoring of changes in the Body Temperature by ch...

2 employees
Health Care, Health and Wellness
Detact Diagnostics vs
Spectrum Antimicrobials
Spectrum Antimicrobials United States

Spectrum Antimicrobials is an infection-control-solutions company with novel antiseptic and disinfec...

13 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Detact Diagnostics

We develop solutions to expensive and life-threatening infections in both the medical and food industries.
Detact Diagnostics was founded in 2014.
Detact Diagnostics is headquartered in The Netherlands.
Detact Diagnostics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on bacterial detection, infection prevention, medical industry and b-Swab.
Detact Diagnostics has approximately 10 employees.
Detact Diagnostics has completed 2 funding rounds, raising a total of $2.10M. The latest funding stage is Venture round.
Top alternatives and competitors to Detact Diagnostics include Nebula Biocides GmbH, TOM Thermochromic, Spectrum Antimicrobials, Gedea Biotech AB, Zilico Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Detact Diagnostics and Nebula Biocides GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Detact Diagnostics, https://bouncewatch.com/company/detact-diagnostics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout